Faridoxorubicin Shows Tumor Shrinkage in Salivary Gland Cancer
Preliminary Phase 1b data is in line with Phase 1a data reported at the European Society of Medical Oncology in September 2025 Avacta Therapeutics, a clinical stage biopharmaceutical company...